Novakand Pharma AB (FRA:3EE0) Short Interest


What is Novakand Pharma AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:3EE0 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Novakand Pharma AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novakand Pharma AB Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novakand Pharma AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Novakand Pharma AB's Short Interest falls into.


Novakand Pharma AB Business Description

Address Nanna Svarts vag 4, Solna, SWE, 171 65
Novakand Pharma AB is developing a new class of innovative drugs focusing on inflammatory diseases and cancer. The company is developing a new class of small molecule drugs that control disease promoting immune cells with precision, by targeting the fractalkine axis.